We are live on ! Find out more
ELC

Edgar Lomax Company Portfolio holdings

AUM $1.4B
1-Year Est. Return 20.67%
This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+20.67%
3 Year Est. Return
+56.64%
5 Year Est. Return
+81.49%
10 Year Est. Return
+226.33%
AUM
$1.61B
AUM Growth
+$5.44M
Cap. Flow
-$59.8M
Cap. Flow %
-3.72%
Top 10 Hldgs %
40.15%
Holding
64
New
1
Increased
1
Reduced
58
Closed
3

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$1.87M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$3.2M
2
MET icon
MetLife
MET
+$2.96M
3
CVS icon
CVS Health
CVS
+$2.91M
4
ALL icon
Allstate
ALL
+$2.57M
5
CSCO icon
Cisco
CSCO
+$2.46M

Sector Composition

Rank Sector Weight
1 Healthcare 24.25%
2 Financials 18.28%
3 Technology 10.27%
4 Consumer Staples 9.91%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
51
Kraft Heinz
KHC
$31.6B
$9.47M 0.59%
232,215
-8,750
-4% -$368K
CL icon
52
Colgate-Palmolive
CL
$73.8B
$9.29M 0.58%
114,150
-5,570
-5% -$455K
TRV icon
53
Travelers Companies
TRV
$78B
$5.32M 0.33%
35,538
-1,737
-5% -$270K
IVE icon
54
iShares S&P 500 Value ETF
IVE
$49.8B
$2.99M 0.19%
20,224
-3,292
-14% -$485K
MO icon
55
Altria Group
MO
$114B
$2.7M 0.17%
56,640
-940
-2% -$46.2K
OGN icon
56
Organon & Co
OGN
$3.56B
$1.72M 0.11%
+56,949
New +$1.87M
SPY icon
57
State Street SPDR S&P 500 ETF Trust
SPY
$821B
$1.58M 0.1%
3,685
-2,449
-40% -$1.02M
BRK.A icon
58
Berkshire Hathaway Class A
BRK.A
$1.1T
$837K 0.05%
2
MKL icon
59
Markel Group
MKL
$23.3B
-260
Closed -$296K

Similar funds

Edgar Lomax Company's Q2 2021 Portfolio in Review

As of Q2 2021, Edgar Lomax Company held 64 positions worth $1.61B, up 0.34% from $1.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Edgar Lomax Company withdrew a net $59.8M in Q2 2021, closing 3 positions and reducing 58 holdings. Its most notable exit was Markel Group, an estimated $296K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

Against the trend, Edgar Lomax Company opened a new position in Organon & Co worth $1.72M.

  • Edgar Lomax Company's largest Q2 2021 buy was Organon & Co: 56,949 shares worth $1.72M.
  • Edgar Lomax Company's biggest Q2 2021 reduction was Merck, cutting an estimated $3.2M.
  • Edgar Lomax Company fully exited Markel Group in Q2 2021, selling an estimated $296K.
  • Edgar Lomax Company's ten largest holdings make up 40% of its $1.61B portfolio in Q2 2021.
  • Edgar Lomax Company opened 1 new position and closed 3 in Q2 2021.
  • Edgar Lomax Company's portfolio value rose 0.34% quarter-over-quarter to $1.61B.

Based on Edgar Lomax Company's 13F filing for Q2 2021, filed 9 Aug 2021.